ArticleJournal of gastrointestinal oncology2022

Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial.

Lanlan Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.